We are live on ! Find out more
ICCC icon

ImmuCell

27 hedge funds and large institutions have $8.67M invested in ImmuCell in 2026 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 4

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

10% more capital invested

Capital invested by funds: $7.87M → $8.67M (+$792K)

4% more funds holding

Funds holding: 2627 (+1)

0.99% more ownership

Funds ownership: 14.15%15.13% (+0.99%)

Holders
27
Holders Change
+1
Holders Change %
+3.85%
% of All Funds
0.33%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
7
Reduced
4
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Jones Financial Companies
26
Jones Financial Companies
Missouri
$124
Wells Fargo
27
Wells Fargo
California
$4
DIG
28
Dauntless Investment Group
New Hampshire
-$244K -39,633 Closed
Bank of America
29
Bank of America
North Carolina
-$12.5K -2,040 Closed
FHA
30
Flagship Harbor Advisors
Massachusetts
-$4.49K -730 Closed

ICCC Hedge Fund Activity: Q1 2026 in Review

27 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q1 2026, worth a combined $8.67M — up 10% from $7.87M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ICCC positions and 3 closed out — a net gain of 2 holders — while 7 added to existing stakes and 4 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $621K. The largest seller was Dauntless Investment Group, exiting entirely with an estimated $244K sold.

  • 27 institutional investors held ImmuCell (ICCC) as of Q1 2026, up from 26 in Q4 2025.
  • Funds reported $8.67M of ImmuCell stock for Q1 2026, up 10% quarter-over-quarter.
  • 5 funds opened new ImmuCell positions in Q1 2026 and 3 closed out, a net change of +2 holders.
  • The largest ImmuCell buyer in Q1 2026 was Morgan Stanley, an estimated $621K added.
  • The largest ImmuCell seller in Q1 2026 was Dauntless Investment Group, an estimated $244K sold.

Based on aggregated 13F filings for Q1 2026.